Cargando…

Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic

INTRODUCTION: During the COVID-19 pandemic, teleconsultation was implemented in clinical practice to limit patient exposure to COVID-19 while monitoring their treatment and follow-up. We sought to examine the satisfaction of patients with breast cancer (BC) who underwent teleconsultations during thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bizot, Alexandra, Karimi, Maryam, Rassy, Elie, Heudel, Pierre Etienne, Levy, Christelle, Vanlemmens, Laurence, Uzan, Catherine, Deluche, Elise, Genet, Dominique, Saghatchian, Mahasti, Giacchetti, Sylvie, Grenier, Juline, Patsouris, Anne, Dieras, Véronique, Pierga, Jean-Yves, Petit, Thierry, Ladoire, Sylvain, Jacot, William, Benderra, Marc-Antoine, De Jesus, Anne, Delaloge, Suzette, Lambertini, Matteo, Pistilli, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480754/
https://www.ncbi.nlm.nih.gov/pubmed/34588616
http://dx.doi.org/10.1038/s41416-021-01555-y
Descripción
Sumario:INTRODUCTION: During the COVID-19 pandemic, teleconsultation was implemented in clinical practice to limit patient exposure to COVID-19 while monitoring their treatment and follow-up. We sought to examine the satisfaction of patients with breast cancer (BC) who underwent teleconsultations during this period. METHODS: Eighteen centres in France and Italy invited patients with BC who had at least one teleconsultation during the first wave of the COVID-19 pandemic to participate in a web-based survey that evaluated their satisfaction (EORTC OUT-PATSAT 35 and Telemedicine Satisfaction Questionnaire [TSQ] scores) with teleconsultation. RESULTS: Among the 1299 participants eligible for this analysis, 53% of participants were undergoing standard post-treatment follow-up while 22 and 17% were currently receiving active anticancer therapy for metastatic and localised cancers, respectively. The mean satisfaction scores were 77.4 and 73.3 for the EORTC OUT-PATSAT 35 and TSQ scores, respectively. In all, 52.6% of participants had low/no anxiety. Multivariable analysis showed that the EORTC OUT-PATSAT 35 score correlated to age, anxiety score and teleconsultation modality. The TSQ score correlated to disease status and anxiety score. CONCLUSION: Patients with BC were satisfied with oncology teleconsultations during the COVID-19 pandemic. Teleconsultation may be an acceptable alternative follow-up modality in specific circumstances.